The Role of HMGB1 in autophagy deficiency-induced liver pathology
The Role of HMGB1 in autophagy deficiency-induced liver pathology
批准号:
9751288
负责人:
XIAO-MING YIN
金额:
$6.17万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-26 至 2020-02-01
关键词:
AddressAffectAlcoholsAutophagocytosisBiologicalBiological ProcessCell DeathCellsChronic DiseaseDNA-Binding ProteinsDevelopmentDietDiseaseEventFibrosisFosteringGrowth FactorHMGB1 geneHepaticHepatocyteHepatomegalyHomeostasisInflammasomeInflammationInflammatoryInjuryLeadLifeLiverLiver diseasesLiver neoplasmsMAP Kinase GeneModalityMolecularNuclearNutrientPathogenesisPathogenicityPathologicPathologyPatternPlayProcessReactionResearchRoleSignal PathwayStem cellsTestingTherapeuticTissuesVirusWorkbasechronic liver diseaseextracellularinjury and repairinsightliver injurymacrophagemembernotch proteinnoveloval cellreceptorreceptor for advanced glycation endproductsrepairedtumortumor microenvironmenttumor progressiontumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Macroautophagy, hereafter referred to as autophagy, is an evolutionarily conserved intracellular
degradation mechanism involved in diverse biological activities and in the pathogenesis of many
diseases. The homeostatic importance of autophagy for the liver is indicated in the fact that
autophagy deficiency causes multiple liver pathologies, including hepatomegaly, injury, inflammation,
ductular reaction, fibrosis and tumorigenesis. What are being triggered by autophagy deficiency to
lead to these changes are largely unknown but understanding the involved mechanisms will provide
the insight not only on how autophagy maintains hepatic homeostasis, but also on how similar
processes occur in other chronic diseases, such as those caused by alcohol, hyper-nutrients, and
hepatic viruses.
Toward that end, we have found that HMGB1 is actively released from autophagy-deficient
hepatocytes, which is different from the more commonly seen case of passive release from dead cells
during injury, but is similar to the active release by macrophages during inflammation. Regulatory
mechanisms including Nrf2 and Caspase1 affect HMGB1 release independently from liver injury.
HMGB1 acts in an extracellular mode and requires its receptor, RAGE, to regulate the ductular
reaction, i.e., the expansion of ductular cells (DRs), also known as hepatic progenitor cells (HPCs) or
oval cells, and to promote the development of hepatic tumors. These results indicate that hepatic
HMGB1 plays an important and unique role in the liver pathogenesis caused by autophagy deficiency.
The proposal have three aims. In Aim 1 we will investigate the mechanism of HMGB1 release
from hepatocytes, addressing the hypothesis that inflammasomes are involved in the process. In Aim
2 we will examine the mechanism of ductular reaction promoted by HMGB1. In Aim 3 we will dissect
the mechanisms of HMGB1 in tumor progression by examining the hypothesis that HMGB1 may alter
the hepatic microenvironment. The successful completion of this work will reveal the novel roles of
hepatocyte-derived HMGB1 in hepatic homeostasis and the results may be generally applicable to
similar pathogenic processes in other types of chronic liver diseases, thus advancing the research in
this field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of HMGB1 in autophagy deficiency-induced liver pathology
-
批准号:10188516
-
项目类别:
-
资助金额:$40.04万
-
财政年份:2018
-
负责人:XIAO-MING YIN
-
依托单位:
The Role of HMGB1 in autophagy deficiency-induced liver pathology
-
批准号:10137441
-
项目类别:
-
资助金额:$35.35万
-
财政年份:2018
-
负责人:XIAO-MING YIN
-
依托单位:
Mechanism and role of selective autophagy in ethanol-induced liver injury
-
批准号:8509479
-
项目类别:
-
资助金额:$18.37万
-
财政年份:2014
-
负责人:XIAO-MING YIN
-
依托单位:
Mechanism and role of selective autophagy in ethanol-induced liver injury
-
批准号:8867956
-
项目类别:
-
资助金额:$14.79万
-
财政年份:2014
-
负责人:XIAO-MING YIN
-
依托单位:
High-Content Cell-Based Screening for Modulators of Autophagy
-
批准号:7453976
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2007
-
负责人:XIAO-MING YIN
-
依托单位:
The impact of growth modulation of liver carcinogenesis
-
批准号:8237696
-
项目类别:
-
资助金额:$9.9万
-
财政年份:2005
-
负责人:XIAO-MING YIN
-
依托单位:
The impact of growth modulation of liver carcinogenesis
-
批准号:7261321
-
项目类别:
-
资助金额:$27.26万
-
财政年份:2005
-
负责人:XIAO-MING YIN
-
依托单位:
The impact of growth modulation of liver carcinogenesis
-
批准号:7430459
-
项目类别:
-
资助金额:$27.26万
-
财政年份:2005
-
负责人:XIAO-MING YIN
-
依托单位:
The impact of growth modulation of liver carcinogenesis
-
批准号:7081233
-
项目类别:
-
资助金额:$28.08万
-
财政年份:2005
-
负责人:XIAO-MING YIN
-
依托单位:
The impact of growth modulation of liver carcinogenesis
-
批准号:7627384
-
项目类别:
-
资助金额:$17.36万
-
财政年份:2005
-
负责人:XIAO-MING YIN
-
依托单位:
The impact of growth modulation of liver carcinogenesis
-
批准号:6968134
-
项目类别:
-
资助金额:$28.75万
-
财政年份:2005
-
负责人:XIAO-MING YIN
-
依托单位:
Bc1-2 Family Proteins in the Ischemic Neuronal Injury
-
批准号:6569380
-
项目类别:
-
资助金额:$24.46万
-
财政年份:2003
-
负责人:XIAO-MING YIN
-
依托单位:
Bc1-2 Family Proteins in the Ischemic Neuronal Injury
-
批准号:7004488
-
项目类别:
-
资助金额:$24.88万
-
财政年份:2003
-
负责人:XIAO-MING YIN
-
依托单位:
Bc1-2 Family Proteins in the Ischemic Neuronal Injury
-
批准号:6697252
-
项目类别:
-
资助金额:$25.67万
-
财政年份:2003
-
负责人:XIAO-MING YIN
-
依托单位:
Bc1-2 Family Proteins in the Ischemic Neuronal Injury
-
批准号:6831662
-
项目类别:
-
资助金额:$25.56万
-
财政年份:2003
-
负责人:XIAO-MING YIN
-
依托单位:
Signal integration of the death receptor pathways
-
批准号:8237720
-
项目类别:
-
资助金额:$15.49万
-
财政年份:2000
-
负责人:XIAO-MING YIN
-
依托单位:
FAS/TNF R1 INITIATED HEPATOCYTE DEATH IN MEDIATE BY BID
-
批准号:6765159
-
项目类别:
-
资助金额:$22.08万
-
财政年份:2000
-
负责人:XIAO-MING YIN
-
依托单位:
FAS/TNF R1 INITIATED HEPATOCYTE DEATH IN MEDIATE BY BID
-
批准号:6377615
-
项目类别:
-
资助金额:$14.85万
-
财政年份:2000
-
负责人:XIAO-MING YIN
-
依托单位:
FAS/TNF R1 INITIATED HEPATOCYTE DEATH IN MEDIATE BY BID
-
批准号:6514224
-
项目类别:
-
资助金额:$21.72万
-
财政年份:2000
-
负责人:XIAO-MING YIN
-
依托单位:
FAS/TNF R1 INITIATED HEPATOCYTE DEATH IN MEDIATE BY BID
-
批准号:6633538
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2000
-
负责人:XIAO-MING YIN
-
依托单位:
海外基金